Autonomous Vehicle Processor Market Trends & Opportunities by 2030

Autonomous vehicles are the key to changing urban transportation beyond recognition in the next few years. Both traditional OEMs and new vehicle developers are working in this ecosystem to improve and introduce fully autonomous vehicles on the road. These vehicles will have advanced features as compared to traditional vehicles and enhance the driving experience for passengers.

The global autonomous vehicle processor market accounted for $5.07 billion in terms of value in 2019 and is expected to reach $42.20 billion by 2030. The market is anticipated to grow at a CAGR of 22.98% during the forecast period 2020-2030. The North America region is expected to grow at a significant growth rate of 24.09% during the forecast period 2020-2030.

Market Segmentation

• Application Type – Level 2, Level 3, Level 4, and Level 5

• Vehicle Type – Passenger Vehicles and Commercial Vehicles

Regional Segmentation

• North America - U.S. and Canada

• Europe – Germany, Netherlands, Sweden, and Rest-of-Europe

• Asia-Pacific and Japan (APJ) - South Korea, Japan, and Rest-of-APJ

• U.K.

• China

• South America

• Middle East and Africa (MEA)

Growth Drivers

• Transportation as a service is poised to accelerate the demand for new autonomous vehicle processors

• Increasing push from the government to develop connected and autonomous infrastructure

Market Challenges

• High-cost structure of autonomous vehicles and their processors

• Lack of advanced infrastructure in developing countries

• Autonomous vehicle protection from hackers is of paramount concern

• Global pandemic impacted the overall supply chain of automotive industry

Market Opportunities

• Tech manufacturers entering into autonomous processors business segment

• Autonomous vehicle platooning technology expected to grow exponentially

Key Companies Profiled

Intel Corporation, NXP Semiconductors N.V., Tesla, Inc., NVIDIA Corporation, Texas Instrument Incorporated, KALRAY Corporation, Renesas Electronic Corporation, Qualcomm Technologies, Inc., Xilinx, Inc., Hailo Technologies Ltd, Ambarella, Inc., AImotive

Request a Sample-https://bisresearch.com/requestsample?id=1059&type=download

Comments

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: • Industry Analysis ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Market Research Reports

Search This Blog